AVANOS MEDICAL INC (AVNS)
US05350V1061 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to AVNS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.97. This target is 28.18% above the current price.
AVNS was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about AVNS.
In the previous month the buy percentage consensus was at a similar level.
AVNS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-25 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-06-21 | Stifel | Reiterate | Hold -> Hold |
| 2023-05-22 | CL King | Initiate | Buy |
| 2023-05-04 | Morgan Stanley | Maintains | Underweight |
| 2023-02-22 | Morgan Stanley | Maintains | Underweight |
| 2023-01-06 | Morgan Stanley | Maintains | Underweight |
| 2022-11-03 | Keybanc | Maintains | Overweight |
| 2022-10-11 | Morgan Stanley | Maintains | Underweight |
| 2022-08-10 | Keybanc | Maintains | Overweight |
| 2022-07-18 | Stifel | Maintains | Hold |
| 2022-07-15 | Morgan Stanley | Maintains | Underweight |
| 2022-05-05 | Morgan Stanley | Maintains | Underweight |
| 2022-02-24 | Keybanc | Maintains | Overweight |
| 2022-01-07 | Morgan Stanley | Maintains | Underweight |
| 2021-08-04 | Keybanc | Maintains | Overweight |
| 2021-08-04 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2021-08-04 | Morgan Stanley | Maintains | Underweight |